Loading company…
PhaBuilder develops biodegradable materials, chemical and pharmaceutical intermediates, and industrial enzymes.
Established in 2021 and based in Beijing, PhaBuilder develops materials and products using synthetic biology, including polyhydroxyalkanoates (PHA). Its products are intended for medical, pharmaceutical, beauty, fiber, and textile applications. The company raised CNY 359 million in Series A funding in February 2023, led by CNPC Kunlun Capital, and has two PHA plants under construction.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in